These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25026539)

  • 1. Chemotherapy-induced peripheral neuropathy #197.
    Fernandez C; Mehta Z; Espenlaub A; Ellison N
    J Palliat Med; 2014 Aug; 17(8):965-6. PubMed ID: 25026539
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.
    Gutiérrez-Gutiérrez G; Sereno M; Miralles A; Casado-Sáenz E; Gutiérrez-Rivas E
    Clin Transl Oncol; 2010 Feb; 12(2):81-91. PubMed ID: 20156778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor.
    van den Bent MJ
    Clin Cancer Res; 2005 Mar; 11(5):1691-3. PubMed ID: 15755989
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetyl-L-carnitine undervalued in the treatment of chemotherapy-induced peripheral neuropathy?
    van Dam DG; Beijers AJ; Vreugdenhil G
    Acta Oncol; 2016 Dec; 55(12):1495-1497. PubMed ID: 27606940
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy-induced peripheral neuropathy: Current status and progress.
    Brewer JR; Morrison G; Dolan ME; Fleming GF
    Gynecol Oncol; 2016 Jan; 140(1):176-83. PubMed ID: 26556766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Supplements and Chemotherapy-Induced Peripheral Neuropathy: Hope or Hype?
    Ligibel JA
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 30053079
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery.
    Storey DJ; Colvin LA; Mackean MJ; Mitchell R; Fleetwood-Walker SM; Fallon MT
    J Pain Symptom Manage; 2010 Jun; 39(6):e2-4. PubMed ID: 20538177
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy-induced peripheral neuropathy: a new treatment option.
    Enck RE
    Am J Hosp Palliat Care; 2012 Nov; 29(7):509-11. PubMed ID: 23074287
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.
    Dunlap B; Paice JA
    J Support Oncol; 2006 Sep; 4(8):398-9. PubMed ID: 17004514
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptoms: Chemotherapy-Induced Peripheral Neuropathy.
    Schneider BP; Hershman DL; Loprinzi C
    Adv Exp Med Biol; 2015; 862():77-87. PubMed ID: 26059930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal peripheral neuropathy following FLA chemotherapy.
    Osborne WL; Holyoake TL; McQuaker IG; Parker AN
    Clin Lab Haematol; 2004 Aug; 26(4):295-6. PubMed ID: 15279668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study.
    Almadrones L; McGuire DB; Walczak JR; Florio CM; Tian C
    Oncol Nurs Forum; 2004 May; 31(3):615-23. PubMed ID: 15146227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness.
    Teoh D; Smith TJ; Song M; Spirtos NM
    Am Soc Clin Oncol Educ Book; 2018 May; 38():469-479. PubMed ID: 30231411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.
    van Laarhoven HW; Verstappen CC; Beex LV; Kappelle AC; Punt CJ
    Anticancer Res; 2003; 23(1B):647-8. PubMed ID: 12680161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency.
    Schloss JM; Colosimo M; Airey C; Vitetta L
    Support Care Cancer; 2015 Jul; 23(7):1843-50. PubMed ID: 25863665
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients.
    Gilchrist L
    Semin Pediatr Neurol; 2012 Mar; 19(1):9-17. PubMed ID: 22641071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Neuropathy After Chemotherapy in Patients With Cancer.
    Holz SC; Wininger YD; Cooper C; Smith SR
    Arch Phys Med Rehabil; 2017 Mar; 98(3):605-607. PubMed ID: 28232002
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peripheral neuropathy produced by cisplatin].
    Valero Jiménez P; Murillo Capitán E; Sánchez Romero JA; Arbizu Ladrón de Guevara ML
    Rev Esp Oncol; 1984; 31(3):511-3. PubMed ID: 6085937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine.
    Griffiths JD; Stark RJ; Ding JC; Cooper IA
    Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.